U S PHYSICAL THERAPY INC /NV (USPH) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 109.91M USD | Liabilities, Current |
| Cash and equivalents | 24.89M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 69.60M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $109.91M | $24.89M | (m) | $69.60M | (m) | (m) |
| 2026-03-31 | (m) | $117.30M | $28.44M | (m) | $69.08M | (m) | (m) |
| 2025-12-31 | (m) | $139.04M | $35.57M | (m) | $64.25M | (m) | (m) |
| 2025-09-30 | (m) | $115.08M | $31.10M | (m) | $67.63M | (m) | (m) |
| 2025-06-30 | (m) | $118.84M | $34.09M | (m) | $65.96M | (m) | (m) |
| 2025-03-31 | (m) | $123.80M | $39.18M | (m) | $64.76M | (m) | (m) |
| 2024-12-31 | (m) | $116.28M | $41.36M | (m) | $59.04M | (m) | (m) |
| 2024-09-30 | (m) | $115.30M | $116.96M | (m) | $57.02M | (m) | (m) |
| 2024-06-30 | (m) | $107.10M | $112.91M | (m) | $54.66M | (m) | (m) |
| 2024-03-31 | (m) | $102.54M | $132.29M | (m) | $55.36M | (m) | (m) |
| 2023-12-31 | (m) | $102.19M | $152.82M | (m) | $51.87M | (m) | (m) |
| 2023-09-30 | (m) | $82.36M | $147.69M | (m) | $52.96M | (m) | (m) |
| 2023-06-30 | (m) | $85.82M | $160.74M | (m) | $54.28M | (m) | (m) |
| 2023-03-31 | (m) | $90.83M | $32.60M | (m) | $56.65M | (m) | (m) |
| 2022-12-31 | (m) | $85.49M | $31.59M | (m) | $51.93M | (m) | (m) |
| 2022-09-30 | (m) | $81.49M | $37.91M | (m) | $49.75M | (m) | (m) |
| 2022-06-30 | (m) | $85.11M | $48.57M | (m) | $50.55M | (m) | (m) |
| 2022-03-31 | (m) | $89.02M | $24.23M | (m) | $49.34M | (m) | (m) |
| 2022-01-01 | (m) | (m) | (m) | (m) | $46.30M | (m) | (m) |
| 2021-12-31 | (m) | $83.48M | $28.57M | (m) | $46.27M | (m) | (m) |
| 2021-09-30 | (m) | $81.67M | $19.19M | (m) | $46.46M | (m) | (m) |
| 2021-06-30 | (m) | $75.38M | $20.42M | (m) | $45.14M | (m) | (m) |
| 2021-03-31 | (m) | $90.83M | $17.94M | (m) | $45.39M | (m) | (m) |
| 2020-12-31 | (m) | $93.49M | $32.92M | (m) | $41.91M | (m) | (m) |
| 2020-09-30 | (m) | $93.20M | $30.13M | (m) | $39.44M | (m) | (m) |
| 2020-06-30 | (m) | $87.35M | $43.55M | (m) | $36.03M | (m) | (m) |
| 2020-03-31 | (m) | $71.15M | $89.55M | (m) | $42.65M | (m) | (m) |
| 2019-12-31 | (m) | $60.56M | $23.55M | (m) | $46.23M | (m) | (m) |
| 2019-09-30 | (m) | $62.80M | $27.86M | (m) | $47.12M | (m) | (m) |
| 2019-06-30 | (m) | $57.02M | $34.86M | (m) | $44.92M | (m) | (m) |
| 2019-03-31 | (m) | $68.93M | $20.24M | (m) | $48.44M | (m) | (m) |
| 2018-12-31 | (m) | $41.95M | $23.37M | (m) | $44.75M | (m) | (m) |
| 2018-09-30 | (m) | $46.96M | $32.24M | (m) | $43.90M | (m) | (m) |
| 2018-06-30 | (m) | $41.89M | $27.15M | (m) | $45.42M | (m) | (m) |
| 2018-03-31 | (m) | $45.38M | $19.81M | (m) | $46.23M | (m) | (m) |
| 2017-12-31 | (m) | $39.55M | $21.93M | (m) | $44.71M | (m) | (m) |
| 2017-09-30 | (m) | $35.99M | $17.42M | (m) | $43.56M | (m) | (m) |
| 2017-06-30 | (m) | $35.19M | $20.24M | (m) | $46.77M | (m) | (m) |
| 2017-03-31 | (m) | $34.03M | $25.15M | (m) | $43.24M | (m) | (m) |
| 2016-12-31 | (m) | $24.62M | $20.05M | (m) | $38.84M | (m) | (m) |
| 2016-09-30 | (m) | $26.38M | $15.02M | (m) | $38.52M | (m) | (m) |
| 2016-06-30 | (m) | $28.98M | $20.45M | (m) | $39.36M | (m) | (m) |
| 2016-03-31 | (m) | $24.18M | $19.21M | (m) | $38.22M | (m) | (m) |
| 2015-12-31 | (m) | $19.01M | $15.78M | (m) | $36.23M | (m) | (m) |
| 2015-09-30 | (m) | $21.36M | $20.56M | (m) | $35.11M | (m) | (m) |
| 2015-06-30 | (m) | $21.70M | $12.97M | (m) | $34.83M | (m) | (m) |
| 2015-03-31 | (m) | $21.40M | $14.56M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $25.50M | $14.27M | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $21.83M | $15.82M | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $22.80M | $12.93M | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $19.34M | $16.76M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $23.17M | $12.90M | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | $16.66M | $12.12M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $17.37M | $10.29M | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $13.90M | $10.28M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $16.31M | $11.67M | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $14.95M | $10.68M | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $16.21M | $8.81M | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $12.52M | $10.44M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $16.32M | $9.98M | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $13.69M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $14.69M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $14.23M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |